ES3049333T3 - Compounds for the treatment of respiratory diseases - Google Patents

Compounds for the treatment of respiratory diseases

Info

Publication number
ES3049333T3
ES3049333T3 ES18795097T ES18795097T ES3049333T3 ES 3049333 T3 ES3049333 T3 ES 3049333T3 ES 18795097 T ES18795097 T ES 18795097T ES 18795097 T ES18795097 T ES 18795097T ES 3049333 T3 ES3049333 T3 ES 3049333T3
Authority
ES
Spain
Prior art keywords
compounds
treatment
respiratory diseases
respiratory
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES18795097T
Other languages
English (en)
Spanish (es)
Inventor
Spencer Williams
Sayali Shah
Zalihe Hakki
Alastair Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianli Biotech Pty Ltd
Original Assignee
Tianli Biotech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017901611A external-priority patent/AU2017901611A0/en
Application filed by Tianli Biotech Pty Ltd filed Critical Tianli Biotech Pty Ltd
Application granted granted Critical
Publication of ES3049333T3 publication Critical patent/ES3049333T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES18795097T 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases Active ES3049333T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2017901611A AU2017901611A0 (en) 2017-05-03 Compounds for the treatment of respiratory diseases
AU2017901647A AU2017901647A0 (en) 2017-05-05 Compounds for the treatment of respiratory diseases
PCT/AU2018/050404 WO2018201192A1 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases

Publications (1)

Publication Number Publication Date
ES3049333T3 true ES3049333T3 (en) 2025-12-16

Family

ID=64015663

Family Applications (1)

Application Number Title Priority Date Filing Date
ES18795097T Active ES3049333T3 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases

Country Status (9)

Country Link
US (2) US20200079757A1 (enExample)
EP (1) EP3619204B1 (enExample)
JP (2) JP7788128B2 (enExample)
CN (1) CN110753688A (enExample)
AU (3) AU2018262108A1 (enExample)
ES (1) ES3049333T3 (enExample)
FI (1) FI3619204T3 (enExample)
PT (1) PT3619204T (enExample)
WO (1) WO2018201192A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4591936A3 (en) 2015-03-23 2025-10-15 Tianli Biotech Pty Ltd Treatment of respiratory diseases
CN113260616B (zh) * 2018-11-07 2025-05-02 天莅生物技术有限公司 用于治疗呼吸系统疾病的新型化合物
CN110452880B (zh) * 2019-09-09 2021-09-21 温州医科大学附属第一医院 急性肺损伤细胞模型的制备方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593991A (en) * 1993-07-16 1997-01-14 Adams; Jerry L. Imidazole compounds, use and process of making
IL110296A (en) * 1993-07-16 1999-12-31 Smithkline Beecham Corp Imidazole compounds process for their preparation and pharmaceutical compositions containing them
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
IL118544A (en) * 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
US6335340B1 (en) * 1997-12-19 2002-01-01 Smithkline Beecham Corporation compounds of heteroaryl substituted imidazole, their pharmaceutical compositons and uses
AU2010311035B2 (en) * 2009-10-28 2013-05-16 Pfizer Inc. Imidazole derivatives as casein kinase inhibitors
CZ2012538A3 (cs) * 2012-08-08 2014-02-19 Masarykova Univerzita Inhibitory pro léčbu B-buněčné chronické lymfocytární leukémie
EP4591936A3 (en) * 2015-03-23 2025-10-15 Tianli Biotech Pty Ltd Treatment of respiratory diseases

Also Published As

Publication number Publication date
JP2023134493A (ja) 2023-09-27
AU2022202774A1 (en) 2022-05-19
US20200079757A1 (en) 2020-03-12
PT3619204T (pt) 2025-10-29
EP3619204B1 (en) 2025-10-01
AU2024200521A1 (en) 2024-02-15
CN110753688A (zh) 2020-02-04
US20220380343A1 (en) 2022-12-01
AU2018262108A1 (en) 2019-11-21
JP7788128B2 (ja) 2025-12-18
AU2024200521B2 (en) 2025-10-02
FI3619204T3 (fi) 2025-11-06
EP3619204A4 (en) 2021-03-24
WO2018201192A1 (en) 2018-11-08
JP2020518621A (ja) 2020-06-25
EP3619204A1 (en) 2020-03-11

Similar Documents

Publication Publication Date Title
IL253062B (en) Pyrazine compounds for the treatment of infectious diseases
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
SI3672954T1 (sl) Spojine, njihove soli in njihova uporaba za zdravljenje bolezni
SMT201900172T1 (it) Ammino triazoli sostituiti utili come inibitori della chitinasi umana
EP4591936A3 (en) Treatment of respiratory diseases
ZA201807509B (en) Di-substituted pyrazole compounds for the treatment of diseases
HUE052766T2 (hu) Neurológiai betegségek kezelése
ZA201906213B (en) Compounds and methods for the treatment of parasitic diseases
IL276482A (en) Compounds for pain management
IL259297A (en) Heterocyclic compounds for the treatment of disease
GB201805100D0 (en) Treatment of sarcopenic diseases
HUE070257T2 (hu) Vegyületek a lipofuscinhoz kapcsolódó betegségek kezelésére
ES3049333T3 (en) Compounds for the treatment of respiratory diseases
PL3761982T3 (pl) Zastosowanie nalfurafiny w leczeniu chorób demielinizacyjnych
GB201717625D0 (en) Device for treatment of chronic respiratory diseases
PL3630754T3 (pl) Związki izoindolinoacetylenowe do leczenia nowotworu
HUE039425T2 (hu) 3,4-Diamino-6-klórpirazin-2-karboxamid vegyületek enac által mediált betegségek kezelésére
PL3710043T3 (pl) Fgf10 do leczenia chorób serca
AU2017901647A0 (en) Compounds for the treatment of respiratory diseases
AU2017901611A0 (en) Compounds for the treatment of respiratory diseases
HK40061035A (en) Novel compounds for the treatment of respiratory diseases
AU2018904241A0 (en) Novel compounds for the treatment of respiratory diseases
AU2015901032A0 (en) Treatment of respiratory diseases